Related Experiment Video
Updated: Mar 13, 2026
09:35
Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
Published on: January 20, 2015
9.3K
Environmental enrichment and social isolation differentially shape catecholaminergic development after early
Romana Šlamberová1, Barbora Čechová1, Jana Jurčovičová1
1Charles University, Third Faculty of Medicine, Department of Physiology, Prague, Czech Republic.
Behavioural Brain Research
|March 11, 2026
Summary
Early methamphetamine exposure impacts brain development, but environmental factors significantly alter these effects. Enriched environments promote neurotransmitter development, while isolation can have opposing effects.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Early methamphetamine exposure disrupts catecholaminergic systems crucial for cognitive and emotional functions.
- Environmental conditions during development can significantly modify neurochemical outcomes.
- Understanding these interactions is vital for addressing developmental neurotoxicity.
Purpose of the Study:
- To investigate the interaction between early methamphetamine exposure and environmental factors on adolescent catecholaminergic development.
- To determine how environmental enrichment and social isolation modulate neurochemical changes induced by methamphetamine.
- To assess the long-term impact of these combined exposures on dopamine and noradrenaline levels.
Main Methods:
- Male Wistar rats received methamphetamine exposure (direct or maternal) during early postnatal development (days 1-12).
- Animals were housed in standard or enriched environments preweaning, followed by group housing or social isolation postweaning.
- Dopamine and noradrenaline concentrations were quantified in the hippocampus and striatum across adolescent stages.
Main Results:
- Environmental enrichment increased striatal and hippocampal dopamine and noradrenaline levels, especially in early to mid-adolescence.
- Postweaning social isolation showed opposing trends, with increased hippocampal noradrenergic activation in mid-adolescence.
- Methamphetamine exposure caused modest neurochemical alterations, with direct exposure yielding more pronounced changes.
- Environmental conditions significantly modulated methamphetamine's neurochemical effects, either buffering or exacerbating them.
Conclusions:
- Environmental context critically shapes catecholaminergic maturation during adolescence.
- Early-life psychostimulant exposure effects are highly dependent on the developmental environment.
- Environmental interventions may offer protective strategies against neurodevelopmental disruptions caused by early drug exposure.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.2K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
01:29Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K